Condensed Statements of Operations | |
Revenues | |
Costs and Expenses | |
Research and development | 1.66M |
Selling, general and administrative | 2.58M |
Impairment loss | |
Total Costs and Expenses | 5.99M |
Loss from Operations | |
Other Income/(Expense) | |
Interest expense | |
Interest income | |
Realized gain on investments | |
Realized gain (loss) on forward contracts | |
Foreign currency transaction gain (loss) | |
Total Other Income/(Expense) | 42.79K |
Net Loss | |
Net Loss Per Share (Basic and diluted) | -0.15 |
Weighted Average Common Shares Outstanding (Basic and diluted) | 80.9M |